OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of a heterologous boost with a recombinant vaccine, NVSI-06-07, in the inactivated vaccine recipients from UAE: a phase 2 randomised, double-blinded, controlled clinical trial
Nawal Al Kaabi, Yun Yang, Jing Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Nawal Al Kaabi, Yun Yang, Jing Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Showing 6 citing articles:
An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines
Saeed Khoshnood, Maniya Arshadi, Sousan Akrami, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 65
Saeed Khoshnood, Maniya Arshadi, Sousan Akrami, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 65
Omicron thwarts some of the world’s most-used COVID vaccines
Elie Dolgin
Nature (2022) Vol. 601, Iss. 7893, pp. 311-311
Open Access | Times Cited: 50
Elie Dolgin
Nature (2022) Vol. 601, Iss. 7893, pp. 311-311
Open Access | Times Cited: 50
“Is Omicron mild”? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3521-3539
Open Access | Times Cited: 29
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3521-3539
Open Access | Times Cited: 29
Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial
Tao Huang, Qianqian Hu, Zhou Xiang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Tao Huang, Qianqian Hu, Zhou Xiang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Effect of Inactivated Vaccines Against SARS-CoV-2 on Immunogenicity Outcome
Yuke Ma, Yukuan Du, Jingnan Yang, et al.
Disaster Medicine and Public Health Preparedness (2024) Vol. 19
Closed Access
Yuke Ma, Yukuan Du, Jingnan Yang, et al.
Disaster Medicine and Public Health Preparedness (2024) Vol. 19
Closed Access
Mix and Match of COVID-19 Vaccines and the Importance of Protein Based Boosters
Mostafa Norizadeh
Iranian Journal of Medical Microbiology (2023) Vol. 17, Iss. 1, pp. 126-127
Open Access
Mostafa Norizadeh
Iranian Journal of Medical Microbiology (2023) Vol. 17, Iss. 1, pp. 126-127
Open Access
